Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Gagnon

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Neuromuscular Disorders : NMD|December 21, 2022
Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1Isabelle Fisette-Paulhus, Cynthia Gagnon, Mélanie Morin
Archives of Physical Medicine and Rehabilitation|March 5, 2019
Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1Kateri Raymond, Mélanie Levasseur, Jean Mathieu, et al.
Muscle & Nerve|October 21, 2017
French translation and cross-cultural adaptation of The Myotonic Dystrophy Health IndexCynthia Gagnon, Marjolaine Tremblay, Isabelle CôTé, et al.
Neuromuscular Disorders : NMD|December 7, 2016
Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal studyBenjamin Gallais, Cynthia Gagnon, Jean Mathieu, et al.
Journal of Texture Studies|October 30, 2018
Comparison of two methods to categorize thickened liquids for dysphagia management in a clinical care setting context: The Bostwick consistometer and the IDDSI Flow Test. Are we talking about the same concept?Claudia Côté, Isabelle Germain, Thérèse Dufresne, et al.
Neuromuscular Disorders : NMD|May 20, 2023
Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?Julie Fortin, Isabelle Côté, Cynthia Gagnon, et al.
Sante Mentale Au Quebec|September 25, 2012
[Evaluation of inappropriate benzodiazepine use among the elderly: risk factors and impacts]Annick Rouleau, Claude Bélanger, Kieron O'Connor, et al.
Orphanet Journal of Rare Diseases|October 1, 2022
Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcomeMarjolaine Tremblay, Laura Girard-Côté, Bernard Brais, et al.
BMC Musculoskeletal Disorders|March 7, 2019
What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping reviewMarie-Pier Roussel, Marika Morin, Cynthia Gagnon, et al.
Muscle & Nerve|November 18, 2014
Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelinesÉmilie Petitclerc, Luc J Hébert, Johanne Desrosiers, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Neuromuscular Disorders : NMD|December 21, 2022
Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1Isabelle Fisette-Paulhus, Cynthia Gagnon, Mélanie Morin
Archives of Physical Medicine and Rehabilitation|March 5, 2019
Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1Kateri Raymond, Mélanie Levasseur, Jean Mathieu, et al.
Muscle & Nerve|October 21, 2017
French translation and cross-cultural adaptation of The Myotonic Dystrophy Health IndexCynthia Gagnon, Marjolaine Tremblay, Isabelle CôTé, et al.
Neuromuscular Disorders : NMD|December 7, 2016
Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal studyBenjamin Gallais, Cynthia Gagnon, Jean Mathieu, et al.
Journal of Texture Studies|October 30, 2018
Comparison of two methods to categorize thickened liquids for dysphagia management in a clinical care setting context: The Bostwick consistometer and the IDDSI Flow Test. Are we talking about the same concept?Claudia Côté, Isabelle Germain, Thérèse Dufresne, et al.
Neuromuscular Disorders : NMD|May 20, 2023
Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?Julie Fortin, Isabelle Côté, Cynthia Gagnon, et al.
Sante Mentale Au Quebec|September 25, 2012
[Evaluation of inappropriate benzodiazepine use among the elderly: risk factors and impacts]Annick Rouleau, Claude Bélanger, Kieron O'Connor, et al.
Orphanet Journal of Rare Diseases|October 1, 2022
Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcomeMarjolaine Tremblay, Laura Girard-Côté, Bernard Brais, et al.
BMC Musculoskeletal Disorders|March 7, 2019
What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping reviewMarie-Pier Roussel, Marika Morin, Cynthia Gagnon, et al.
Muscle & Nerve|November 18, 2014
Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelinesÉmilie Petitclerc, Luc J Hébert, Johanne Desrosiers, et al.
Pageof 15